2019 American Transplant Congress Archives - Page 16 of 214

4:54pm-5:06pm: Early Impact of the New United Network for Organ Sharing Simultaneous Liver-Kidney Transplantation Allocation Policy: Improved Standardization but Similar Utilization

G. Cullaro¹, E. C. Verna², J. C. Lai¹

Concurrent Session: Liver - Kidney Issues in Liver Transplantation • Room 302

4:54pm-5:06pm: Gender Disparity In Access To Liver Transplant Larger In White Than Black Patients

K. Guo, J. Peipert, M. Abecassis, L. Zhao, D. Ladner

Concurrent Session: Non-Organ Specific: Disparities and Access to Healthcare II • Room 208

4:54pm-5:06pm: Hepatitis C Treatment and Transplant Outcomes in Liver Transplant Recipients with Hepatitis C Positive Donors

I. Booth, J. Clark, J. C. LaMattina, A. Haririan, R. N. Barth, B. Ravichandran

Concurrent Session: Non-Organ Specific: Viral Hepatitis • Room 309

4:54pm-5:06pm: Impact of Recipient Age in Combined Liver-Kidney Transplantation (CLKT): Caution is Needed for Elderly Patients≥70 Years

B. Ekser¹, W. C. Goggins¹, R. S. Mangus¹, P. Mihaylov¹, J. A. Fridell¹, M. A. Lacerda², M. S. Ghabril², J. A. Powelson¹, C. A. Kubal¹

Concurrent Session: Liver: Recipient Selection • Room 312

4:54pm-5:06pm: Improving Living Donor Follow Up

L. Aronoff, V. Nair, C. Flores, M. Bhaskaran, E. Molmenti, A. Fahmy, M. Zhou, E. Grodstein, D. Campbell, C. Literello, L. Teperman

Concurrent Session: Quality Assurance Process Improvement & Regulatory Issues II • Room 210

4:54pm-5:06pm: Improving Medication Adherence and Outcomes in Adult Kidney Transplant Patients Using SystemCHANGE^TM: Results of the Medication Adherence Given Individual Change (MAGIC) Randomized Clinical Trial

M. R. Wakefield¹, C. M. Ashbaugh², L. Remy³, D. Aholt³, C. Miller³, S. Ye³, D. K. Hathaway⁴, D. Clark⁴, V. S. Staggs⁵, K. Goggin⁶, R. J. Ellis⁷, C. L. Russell³

Concurrent Session: Kidney Immunosuppression: Novel Regimens and Drug Minimization III • Veterans Auditorium

4:54pm-5:06pm: Monitoring Circulating T Follicular Helper Cells Polarization, Activation and Function Distinguishes Asymptomatic Donor-Specific Anti-HLA Antibody Positive Kidney Transplant Recipients from Those Undergoing Antibody-Mediated Rejection

C. Macedo¹, K. Louis¹, P. Fadakar², M. Yamada², B. Elinoff¹, K. Hadi¹, P. Randhawa¹, D. Metes¹

Concurrent Session: Biomarkers, Immune Monitoring and Outcomes V • Room 306

4:54pm-5:06pm: Positron Emission Tomography (PET-CT) Global Coronary Flow Reserve (CFR) Stratifies Cardiovascular Risk among Renal Transplant (RTx) Candidates

M. Minder, S. Mason, J. Ethington, R. McCubrey, D. Min, N. Sekaran, J. Orford, D. Morris, S. Anand, T. Srinivas

Concurrent Session: Kidney: Cardiovascular and Metabolic III • Ballroom C

4:54pm-5:06pm: To Each Their Own: Center-Level Variation in Tailoring Induction Immunosuppression to Kidney Transplant Recipients

S. Bae, A. Massie, J. Garonzik Wang, M. McAdams DeMarco, J. Coresh, D. Segev

Concurrent Session: Kidney Immunosuppression: Induction Therapy • Room 304

4:54pm-5:06pm: Treg Suppressor Function within Allografts is Required for Tolerance

J. Ossart, A. Pena, H. Dai, L. Bauer, A. Williams, G. Camirand

Concurrent Session: Late Breaking Oral Abstract • Room 206